Citation: | GAO Yan, WANG Zhongqiao. Correlation of lncRNA ANCR expression with clinicopathological characteristics in nasopharyngeal carcinoma tissues[J]. Journal of Clinical Medicine in Practice, 2025, 29(3): 1-5. DOI: 10.7619/jcmp.20244692 |
To investigate the correlation between the expression of long non-coding RNA anti-differentiation non-coding RNA (lncRNA ANCR) and clinicopathological characteristics in nasopharyngeal carcinoma tissues.
A total of 115 patients pathologically diagnosed as nasopharyngeal carcinoma in the hospital from June 2015 to June 2019 were randomly included as research objects, and real-time fluorescent quantitative PCR was used to detect the expression level of lncRNA ANCR in tumor tissues and adjacent normal tissues. Correlations of lncRNA ANCR expression with gender, age, pathological type, maximum diameter, differentiation grade, clinical stage, and lymph node metastasis were analyzed. Patients were followed up for 60 months to record tumor progression and overall survival.
The expression level of lncRNA ANCR in tumor tissues was significantly higher than that in adjacent normal tissues (P<0.001). Patients with a maximum diameter ≥3 cm, low differentiation, stage Ⅲ to Ⅳ, and positive lymph node metastasis had significantly higher lncRNA ANCR expression level in tumor tissues than those with a maximum diameter<3 cm, moderate-to-high differentiation, stage Ⅰ to Ⅱ, and negative lymph node metastasis (P<0.001). Patients with tumor progression and death outcome had significantly higher lncRNA ANCR expression level in tumor tissues than those without tumor progression and survival outcome (P<0.001). Multivariate Logistic regression analysis showed that a maximum diameter ≥3 cm, stage Ⅲ to Ⅳ, positive lymph node metastasis, and lncRNA ANCR expression were significantly related to tumor progression, while stage Ⅲ to Ⅳ and lncRNA ANCR expression were significantly related to death (P<0.001). The receiver operating characteristic (ROC) curve showed that the areas under the curve (AUC) for predicting tumor progression and death based on lncRNA ANCR expression level in tumor tissues were 0.899 and 0.842, respectively (P<0.001). The Kaplan-Meier survival curve showed that the 5-year survival rate in the high lncRNA ANCR expression group was significantly lower than that in the low lncRNA ANCR expression group in tumor tissues (P<0.01).
High expression of lncRNA ANCR in tumor tissues may be involved in the malignant progression of nasopharyngeal carcinoma, and is closely related to clinical prognosis.
[1] |
王丹丹. 老年结肠癌患者外周血单个核细胞LncRNA ANCR和LncRNA NEAT1表达及其与病理特征、预后的关系[J]. 中国老年学杂志, 2022, 42(24): 5965-5968. doi: 10.3969/j.issn.1005-9202.2022.24.011
|
[2] |
饶德新, 潘丽红, 刘恒, 等. 血清LncRNA ANCR、LncRNA LINC00355与非小细胞肺癌临床病理特征及预后的关系[J]. 实用癌症杂志, 2022, 37(4): 556-559, 582. doi: 10.3969/j.issn.1001-5930.2022.04.009
|
[3] |
朱婷婷, 夏一函, 孙莎莎, 等. lncRNA ANCR调控miR-497-5p对胃癌细胞血管管腔形成及凋亡的影响[J]. 中国临床研究, 2024, 37(2): 216-222.
|
[4] |
史正亮, 张华, 范志勇, 等. lncRNA ANCR调节骨质疏松大鼠脂肪源性干细胞分化成骨细胞及对Wnt信号通路的作用机制[J]. 中国骨质疏松杂志, 2021, 27(9): 1249-1253, 1268. doi: 10.3969/j.issn.1006-7108.2021.09.001
|
[5] |
张峰, 徐瑞. 淫羊藿苷对兔骨质疏松的疗效及骨组织MEG3、H19和DANCR表达的影响[J]. 山西医科大学学报, 2019, 50(7): 971-975.
|
[6] |
SONG X Z, XU X J, REN X N, et al. LncRNA ANCR suppresses the progression of hepatocellular carcinoma through the inhibition of Wnt/β-catenin signaling pathway[J]. Onco Targets Ther, 2020, 13: 8907-8917. doi: 10.2147/OTT.S260556
|
[7] |
WU H X, HE P X, XIE D, et al. Long-noncoding RNA ANCR activates the hedgehog signaling pathway to promote basal cell carcinoma progression by binding to PTCH[J]. Clin Cosmet Investig Dermatol, 2022, 15: 955-965. doi: 10.2147/CCID.S345371
|
[8] |
MA X K, YUAN Y F, LU J B, et al. Long noncoding RNA ANCR promotes migration, invasion, EMT progress and stemness of nasopharyngeal carcinoma cells via the miR-4731-5p/NMT1 axis[J]. Pathol Res Pract, 2021, 224: 153540. doi: 10.1016/j.prp.2021.153540
|
[9] |
ZHOU T, FANG J J, ZHOU Y X, et al. Long non-coding RNA ANCR promotes progression of NSCLC by inhibiting E-Ca expression[J]. Eur Rev Med Pharmacol Sci, 2020, 24(3): 1250-1257. http://pubmed.ncbi.nlm.nih.gov/32096155/
|
[10] |
朱金庚, 刘永, 涂志刚. LncRNA-ANCR介导PI3K及AKT蛋白对人胃癌细胞增殖迁移的作用机制[J]. 西部医学, 2019, 31(9): 1334-1338, 1343. doi: 10.3969/j.issn.1672-3511.2019.09.005
|
[11] |
GUO C B, MA X K, HE H L, et al. Expression of ANCR in nasopharyngeal carcinoma patients and its clinical significance[J]. Medicine, 2021, 100(33): e26834. doi: 10.1097/MD.0000000000026834
|
[12] |
NI C Y, TENG P, HU P. Effects of ANCR lncRNA on the biological behaviors of lung cancer cells A549 and the mechanism[J]. Transl Cancer Res, 2020, 9(8): 4693-4702. doi: 10.21037/tcr-20-483
|
[13] |
HU X, WEN Y, TAN L Y, et al. Exosomal long non-coding RNA ANCR mediates drug resistance in osteosarcoma[J]. Front Oncol, 2022, 11: 735254. doi: 10.3389/fonc.2021.735254
|
[14] |
TA W W, ZHANG Y, ZHANG S D, et al. LncRNA ANCR downregulates hypoxia-inducible factor 1α and inhibits the growth of HPV-negative cervical squamous cell carcinoma under hypoxic conditions[J]. Mol Med Rep, 2020, 21(1): 413-419.
|
[15] |
LIU B, ZHAO H Y, ZHANG L L, et al. Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway[J]. BMC Cancer, 2019, 19(1): 1112. doi: 10.1186/s12885-019-6335-4
|
[16] |
JIANG C Y, SHI X B, YI D D, et al. Long non-coding RNA anti-differentiation non-coding RNA affects proliferation, invasion, and migration of breast cancer cells by targeting miR-331[J]. Bioengineered, 2021, 12(2): 12236-12245. doi: 10.1080/21655979.2021.2005989
|
[17] |
陈辉国, 周亚夫, 颜建华, 等. 长链非编码RNA ANCR在肺癌中的表达和作用[J]. 中国临床药理学杂志, 2021, 37(6): 685-689.
|
[18] |
岳琰, 唐忠胜, 陈汇. lncRNA ANCR对直肠癌细胞增殖和凋亡能力的影响及机制[J]. 肿瘤代谢与营养电子杂志, 2020, 7(3): 340-346.
|
[19] |
刘玉华, 魏蔚, 崔淑萍. LncRNA ANCR调控miR-331表达影响胃癌细胞的生物学行为[J]. 中国癌症杂志, 2019, 29(1): 19-25.
|
[20] |
张磊, 何越峰, 张莉, 等. 长链非编码RNA DEANR1等在肺癌中的表达[J]. 中国医药导报, 2019, 16(18): 9-11.
|
[21] |
MA X K, ZHOU J Y, LIU J Y, et al. LncRNA ANCR promotes proliferation and radiation resistance of nasopharyngeal carcinoma by inhibiting PTEN expression[J]. Onco Targets Ther, 2018, 11: 8399-8408. doi: 10.2147/OTT.S182573
|
[22] |
WEN Z L, LIAN L Y, DING H, et al. LncRNA ANCR promotes hepatocellular carcinoma metastasis through upregulating HNRNPA1 expression[J]. RNA Biol, 2020, 17(3): 381-394. doi: 10.1080/15476286.2019.1708547
|
[23] |
CHENG C D, DONG Y F, RU X Y, et al. LncRNA ANCR promotes glioma cells invasion, migration, proliferation and inhibits apoptosis via interacting with EZH2 and repressing PTEN expression[J]. Cancer Gene Ther, 2021, 28(9): 1025-1034. doi: 10.1038/s41417-020-00263-8
|
1. |
王晓娜,尹健,赵艳春. 右美托咪定联合利多卡因对脑肿瘤切除手术患者的脑保护效应. 贵州医科大学学报. 2023(02): 222-227 .
![]() | |
2. |
何丽丽,周兴,刘媛媛,雷亨发,何军民. 右美托咪定联合纳布啡或舒芬太尼用于老年患者钻孔引流术的临床效果. 江苏医药. 2023(05): 487-490 .
![]() | |
3. |
周美含. 右美托咪定对老年患者全身麻醉术后认知功能障碍的影响. 中华养生保健. 2023(02): 185-187 .
![]() | |
4. |
赵亮,徐阳阳. 右美托咪定对脑膜瘤患者脑源性神经生长因子水平及认知功能的影响. 中国肿瘤临床与康复. 2022(08): 902-905 .
![]() | |
5. |
郭其发,杨成亮,王艺丹,沈通桃. 无阿片药麻醉诱导对气管插管患者血流动力学的影响. 实用临床医药杂志. 2022(22): 56-59 .
![]() | |
6. |
申素峰,李景义,胡强夫. 右美托咪定与丙泊酚复合麻醉对脑膜瘤手术患者的麻醉效果及对血流动力学及脑组织的保护作用. 实用癌症杂志. 2022(12): 1971-1974 .
![]() |